Skip to content
CritiTech Particle Engineering Solutions logo — Multi-Service Pharmaceutical Contract Development Manufactur...

CritiTech Particle Engineering Solutions

Multi-Service Pharmaceutical Contract Development Manufacturing Organization (CDMO)

Founded 2001 United States Lawrence, United States 20 employees Venture round Total: $13.21M Biotechnology, Pharmaceutical

General Information

Company Name CritiTech Particle Engineering Solutions
Founded Year 2001
Location United States Lawrence, United States
Employees 20
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CritiTech Particle Engineering Solutions. To contact CritiTech Particle Engineering Solutions, visit crititech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CritiTech Particle Engineering Solutions compare?

A PDF of CritiTech Particle Engineering Solutions and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CritiTech Particle Engineering Solutions soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CritiTech Particle Engineering Solutions

**CritiTech Particle Engineering Solutions** is a rapidly-growing, multi-service pharmaceutical Contract Development Manufacturing Organization (CDMO) and Contract Research Organization (CRO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early-stage drug development, and pre-clinical and clinical manufacturing. Founded in **2001** and headquartered in the **United States**, the company provides a suite of CDMO services, helping its customers develop new drugs and improved next generation particles from proof-of-concept through Phase III cGMP clinical production. CritiTech Particle Engineering Solutions uses two primary technologies - *Spray Drying* and *Supercritical Precipitation* - to help its customers engineer, formulate and manufacture their drugs. The latest investment of **$7.50M** was made in a **Venture Round** on **01 April 2019** and the investor involved was **Accelerate Venture Partners**. The company operates in the **Biotechnology** and **Pharmaceutical** industries.

Business keywords: Pharmaceutical CDMO, Contract Development Manufacturing Organization, Particle Engineering, Material Characterization, Analytical Testing, Drug Development, Pre-clinical Manufacturing, Clinical Manufacturing, Spray Drying, Supercritical Precipitation, CRO, Phase III cGMP, Proof-of-Concept, Pharmaceutical Services, Drug Formulation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $7.50M 1
Accelerate Venture Partners
01 Apr 2019
Debt Financing $1.18M -
18 Jan 2013
Debt Financing $3.00M -
02 Apr 2012
Angel Round $480.00K -
31 Dec 2010
Venture Round $1.05M -
10 Dec 2009

CritiTech Particle Engineering Solutions Alternatives & Competitors

View All Alternatives
CritiTech Particle Engineering Solutions vs

Sound Solution for Manufacturing

Series A
33 employees
Biopharma, Biotechnology
CritiTech Particle Engineering Solutions vs

Your Integrated CDMO Specialist. Driven by experts, led by science.

Private Equity
123 employees
Biotechnology, Industrial
CritiTech Particle Engineering Solutions vs

One product: Commitment.

91 employees
Biotechnology, Health Care

FAQ About CritiTech Particle Engineering Solutions

Multi-Service Pharmaceutical Contract Development Manufacturing Organization (CDMO)
CritiTech Particle Engineering Solutions was founded in 2001.
CritiTech Particle Engineering Solutions is headquartered in Lawrence, United States.
CritiTech Particle Engineering Solutions operates in Biotechnology and Pharmaceutical. Its work centres on Pharmaceutical CDMO, Contract Development Manufacturing Organization, Particle Engineering and Material Characterization.
CritiTech Particle Engineering Solutions has approximately 20 employees.
CritiTech Particle Engineering Solutions has completed 5 funding rounds, raising a total of $13.21M. The latest funding stage is Venture round.
Top alternatives and competitors to CritiTech Particle Engineering Solutions include Chime Biologics, Upperton Pharma Solutions, KABS Laboratories Inc., Biokey, Inc., Anthem Biosciences Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CritiTech Particle Engineering Solutions and Chime Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CritiTech Particle Engineering Solutions, https://bouncewatch.com/company/crititech-particle-engineering-solutions, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout